标普和纳斯达克内在价值 联系我们

Curaleaf Holdings, Inc. CURLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.02
+442.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Curaleaf Holdings, Inc. (CURLF) .

本页证实的标准:

  • VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+442.5%).
  • 分析师共识目标价 $13.02 (+442.5% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分: 47/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
未來
73/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
~
护城河
51/100
→ Income
~
成长
48/100
→ Income
收入
10/100
→ Income

估值概览 — CURLF

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.42
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.31
每股账面价值$0.00
每股营收$1.69
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$13.02 (+442.5%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-0.10 $3.71M $-118.18K -3.2%
2017 $-0.02 $19.31M $-5.04M -26.1%
2018 $-0.16 $77.06M $-61.88M -80.3%
2019 $-0.15 $221.02M $-69.85M -31.6%
2020 $-0.11 $626.64M $-61.33M -9.8%
2021 $-0.16 $1.21B $-109.13M -9%
2022 $-0.53 $1.34B $-376.93M -28.2%
2023 $-0.40 $1.35B $-281.2M -20.9%
2024 $-0.29 $1.34B $-215.42M -16%
2025 $-0.31 $1.29B $-235.12M -18.2%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言